Eginition Hospital

Athens 11528

3 studies enrolling now · 8 studies all time

What they study most

Alzheimer Disease, Amyotrophic Lateral Sclerosis, Generalized Tonic Clonic Seizures, Pompe Disease, Pompe Disease (Late-onset), Schizophrenia

Studies at this site

• A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1) — Recruiting now
• A Global Prospective Observational Registry of Patients With Pompe Disease — Recruiting now
• Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients — Recruiting now
• A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study — Stopped early
• A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With Late-Onset Pompe Disease (LOPD) — Completed
• Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1) — Completed
• A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures. — Completed
• BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease. — Completed